{"id":"https://openalex.org/W2953672345","doi":"https://doi.org/10.1158/1538-7445.sabcs18-1382","title":"Abstract 1382: Megakaryocyte potentiating factor as a predictive biomarker for therapies against malignant mesothelioma","display_name":"Abstract 1382: Megakaryocyte potentiating factor as a predictive biomarker for therapies against malignant mesothelioma","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W2953672345","doi":"https://doi.org/10.1158/1538-7445.sabcs18-1382","mag":"2953672345"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs18-1382","doi":"https://doi.org/10.1158/1538-7445.sabcs18-1382","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-1382","pdf_url":null,"source":{"id":"https://openalex.org/S4306506411","display_name":"Clinical Research (Excluding Clinical Trials)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Research (Excluding Clinical Trials)","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026986071","display_name":"Liang Cao","orcid":"https://orcid.org/0000-0001-7293-8338","observed_orcids":["https://orcid.org/0000-0001-7293-8338"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liang Cao","raw_affiliation_strings":["National Cancer Inst., Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Inst., Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041170114","display_name":"Yunkai Yu","orcid":"https://orcid.org/0000-0001-6390-7097","observed_orcids":["https://orcid.org/0000-0001-6390-7097","https://orcid.org/0000-0002-6476-9017"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yunkai Yu","raw_affiliation_strings":["National Cancer Inst., Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Inst., Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074644543","display_name":"Anish Thomas","orcid":"https://orcid.org/0000-0003-3293-3115","observed_orcids":["https://orcid.org/0000-0003-3293-3115"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anish. Thomas","raw_affiliation_strings":["National Cancer Inst., Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Inst., Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100677413","display_name":"Jingli Zhang","orcid":"https://orcid.org/0000-0002-8590-5233","observed_orcids":["https://orcid.org/0000-0002-8590-5233"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jingli Zhang","raw_affiliation_strings":["National Cancer Inst., Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Inst., Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086855365","display_name":"Masanori Onda","orcid":"https://orcid.org/0000-0002-6805-2152","observed_orcids":["https://orcid.org/0000-0002-6805-2152"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Masanori Onda","raw_affiliation_strings":["National Cancer Inst., Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Inst., Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023012274","display_name":"Paul S. Meltzer","orcid":"https://orcid.org/0000-0003-0963-1768","observed_orcids":["https://orcid.org/0000-0003-0963-1768"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Meltzer","raw_affiliation_strings":["National Cancer Inst., Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Inst., Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029872582","display_name":"Raffit Hassan","orcid":"https://orcid.org/0000-0002-4012-3633","observed_orcids":["https://orcid.org/0000-0002-4012-3633"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raffit Hassan","raw_affiliation_strings":["National Cancer Inst., Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Inst., Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056573254","display_name":"Ira H Pastan","orcid":"https://orcid.org/0000-0002-9223-0270","observed_orcids":["https://orcid.org/0000-0002-9223-0270"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ira Pastan","raw_affiliation_strings":["National Cancer Inst., Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Inst., Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210140884"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1382","last_page":"1382"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/malignant-mesothelioma","display_name":"malignant mesothelioma","score":0.9350000023841858},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8830000162124634},{"id":"https://openalex.org/keywords/mesothelin","display_name":"mesothelin","score":0.8930000066757202},{"id":"https://openalex.org/keywords/treatment-response-monitoring","display_name":"treatment response monitoring","score":0.7820000052452087},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8159999847412109},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9599999785423279},{"id":"https://openalex.org/keywords/disease-progression-monitoring","display_name":"disease progression monitoring","score":0.5860000252723694},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C2777407522","wikidata":"https://www.wikidata.org/wiki/Q1077603","display_name":"Mesothelioma","level":2,"score":0.8081333637237549},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.6481234431266785},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5491129159927368},{"id":"https://openalex.org/C2779705218","wikidata":"https://www.wikidata.org/wiki/Q821701","display_name":"Megakaryocyte","level":4,"score":0.5363496541976929},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49832630157470703},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4338071942329407},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41070666909217834},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32033461332321167},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3018462061882019},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2773990035057068},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23787373304367065},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.05402734875679016},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.0},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs18-1382","doi":"https://doi.org/10.1158/1538-7445.sabcs18-1382","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-1382","pdf_url":null,"source":{"id":"https://openalex.org/S4306506411","display_name":"Clinical Research (Excluding Clinical Trials)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Research (Excluding Clinical Trials)","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2800390367","https://openalex.org/W2785602236","https://openalex.org/W1971468779","https://openalex.org/W2043477702","https://openalex.org/W2590881190","https://openalex.org/W2339799462","https://openalex.org/W2110147320","https://openalex.org/W2569332087","https://openalex.org/W2739680755","https://openalex.org/W2556420637"],"abstract_inverted_index":{"Objectives:":[0],"Effective":[1],"biomarkers":[2],"for":[3,9,37,41,63,101,111,313,396,408],"malignant":[4,399],"mesothelioma":[5,400],"(MM)":[6],"are":[7],"needed":[8],"clinical":[10,32,55,80,335],"management":[11],"and":[12,40,45,75,79,94,110,184,263,285,288,294,309,339],"the":[13,67,88,205,292,307,317,320,362,405],"development":[14],"of":[15,31,57,127,155,176,306,319,350,404],"cell":[16],"surface":[17],"mesothelin-targeted":[18,43],"therapies.":[19],"We":[20],"evaluated":[21,100],"serum":[22,48,64,122,177,261,279,344],"megakaryocyte":[23],"potentiating":[24,390],"factor":[25,391],"(MPF)":[26],"as":[27,204,392],"a":[28,71,125,131,152,159,173,201,210,311,325,348,369,393],"biomarker":[29,395],"predictive":[30,394],"outcome":[33,95,157],"in":[34,53,91,118,179,275,304,329,357,368],"MM":[35,51,119,147,207,252,298,359],"patients,":[36,120,148,253,278,299,360],"patient":[38],"monitoring,":[39],"developing":[42],"therapies.Patients":[44],"Methods:":[46],"Serial":[47],"samples":[49],"from":[50,191,225,245],"patients":[52,180,208,232,308],"two":[54],"trials":[56],"an":[58,102,107,188,256,267,353],"anti-mesothelin":[59,108,269,355],"immunotoxin":[60],"were":[61,84],"tested":[62],"MPF.":[65],"For":[66],"purpose,":[68],"we":[69],"developed":[70],"new":[72],"MPF":[73,97,123,150,178,262,280,301,330,345],"assay":[74],"conducted":[76],"both":[77,337],"analytical":[78],"validation.":[81],"Correlative":[82],"studies":[83],"performed":[85],"to":[86,106,193,197,227,247,266,290,352,365],"determine":[87],"test":[89],"effectiveness":[90],"treatment":[92],"monitoring":[93],"prediction.":[96],"was":[98,172,255,281,302,331],"further":[99,233],"association":[103,257],"with":[104,130,158,181,187,209,222,242,333],"response":[105,265,277,293,351],"therapy":[109,270,356],"disease":[112,295],"monitoring.Results:":[113],"Our":[114],"data":[115],"showed":[116],"that":[117],"elevated":[121,149,182,259,300,342],"is":[124,151,310],"predictor":[126,154,312,349],"poor":[128,156,314],"survival":[129,217,237],"hazard":[132],"ratio":[133],"(HR)":[134],"=":[135,140,143,161,166,169,240,272],"2.46":[136],"(Log":[137,163],"Rank":[138,164],"P":[139,165],"0.003;":[141],"n":[142,168],"95).":[144],"In":[145,250,297],"refractory":[146,251,358],"strong":[153],"HR":[160],"6.12":[162],"0.0007;":[167],"57).":[170],"There":[171],"significant":[174],"reduction":[175,328],"baseline":[183,343],"radiological":[185,264],"response,":[186],"average":[189],"change":[190,203],"-52%":[192],"-78%":[194],"after":[195],"1":[196],"6":[198],"cycles.":[199],"Using":[200],"-50%":[202,327],"cutoff,":[206],"positive":[211],"MPF-response":[212,231],"had":[213],"significantly":[214],"improved":[215,235,334],"progression-free":[216],"(PFS)":[218],"(P":[219,239,271],"<":[220],"0.0001),":[221],"median":[223,243],"extended":[224,244],"1.9":[226],"11.3":[228],"months.":[229,249],"These":[230],"exhibited":[234],"overall":[236],"(OS)":[238],"0.004),":[241],"8.8":[246],"22.3":[248],"there":[254],"between":[258,283],"pre-treatment":[260],"experimental":[268,354],"0.033).":[273],"Furthermore,":[274],"these":[276],"monitored":[282],"32.2":[284],"63.8":[286],"months":[287],"found":[289],"reflect":[291],"progression.Conclusion:":[296],"observed":[303],"2/3rd":[305],"survival,":[315],"throughout":[316],"course":[318],"disease.":[321],"Following":[322],"systemic":[323],"therapies,":[324],">":[326],"associated":[332],"outcome,":[336],"PFS":[338],"OS.":[340],"An":[341],"may":[346],"be":[347,366],"however,":[361],"finding":[363],"needs":[364],"confirmed":[367],"larger":[370],"study.Citation":[371],"Format:":[372],"Liang":[373],"Cao,":[374],"Yunkai":[375],"Yu,":[376],"Anish.":[377],"Thomas,":[378],"Jingli":[379],"Zhang,":[380],"Masanori":[381],"Onda,":[382],"Paul":[383],"Meltzer,":[384],"Raffit":[385],"Hassan,":[386],"Ira":[387],"Pastan.":[388],"Megakaryocyte":[389],"therapies":[397],"against":[398],"[abstract].":[401],"In:":[402],"Proceedings":[403],"American":[406],"Association":[407],"Cancer":[409,423],"Research":[410],"Annual":[411],"Meeting":[412],"2019;":[413],"2019":[414],"Mar":[415],"29-Apr":[416],"3;":[417],"Atlanta,":[418],"GA.":[419],"Philadelphia":[420],"(PA):":[421],"AACR;":[422],"Res":[424],"2019;79(13":[425],"Suppl):Abstract":[426],"nr":[427],"1382.":[428]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2019-07-12T00:00:00"}